Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News enVVeno Medical Corporation NVNO

Healthcare Medical Devices
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company’s lead product is the VenoValve, a replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient... see more

Current News (NDAQ:NVNO)

enVVeno Medical Announces Reverse Stock Split

ACCESS Newswire 9 days ago

enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment

ACCESS Newswire November 26, 2025

enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve

ACCESS Newswire November 13, 2025

enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update

ACCESS Newswire October 31, 2025

enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment

ACCESS Newswire September 26, 2025

enVVeno Medical Updates Regulatory Status of VenoValve(R)

ACCESS Newswire September 15, 2025

enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R)

ACCESS Newswire August 20, 2025

enVVeno Medical to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

ACCESS Newswire August 15, 2025

Health Economic Study Shows That enVVeno Medical's VenoValve(R) Would be a Cost-Effective Treatment Option for Patients with Severe Chronic Venous Insufficiency

ACCESS Newswire August 6, 2025
View More News ››

Opinion & Analysis (NDAQ:NVNO)

Texas Heart Takes to the CoreoGraft

Streetwise Reports October 11, 2018
View More Opinion ››

Bullboard Posts (NDAQ:NVNO)

Sell buddy sell.Wow.

Otherwise you guys out there will be losing your money with this stock today anyway
coolfooldumbguy - August 20, 2025

enVVeno Medical Corporation (NASDAQ:NVNO) – A Promisin

http://beyondspx.com/2024/08/01/envveno-medical-corporation-nasdaqnvno-a-promising-bioprosthetic-solution-for-chronic-venous...
MikeTester - August 2, 2024

RE:FDA LIFT-OFF

Still on progress: https://www.webmd.com/dvt/bioprosthetic-venous-valve-dvt "Why It’s Ground-Breaking The VenoValve is the first...
PierreC - July 31, 2024

FDA LIFT-OFF

Looks like positive results are on the verge of better days ahead for both patients and investors. 
Teccing - March 9, 2024

HJLI ..... N.L.O.D

Sonnamabeotch
Iseneschal - August 3, 2021

HJLI ...what can I say?

F&%K !!!!!!!!!!!! Stopped out
Iseneschal - August 3, 2021
View more Bullboard ››

SEGO Resources Inc.

SEGO Resources Inc.

Sego Resources Inc., an exploration stage company, engages in the acquisition, exploration, and evaluation of mineral ...
View More »

Podcasts